Xipere green-lit by FDA
Xipere, the first product for injection into the suprachoroidal space to treat macular oedema associated with uveitis, has been granted US Food and Drug Administration (FDA) approval.
Staff reporters1 min read
Ophthalmology News
Mitomycin C after crosslinking increases corneal haze
Mitomycin C (MMC), applied to inhibit incoming keratocytes after corneal crosslinking (CXL), increases corneal haze, according to the authors of a study in Lebanon.
Staff reporters1 min read
Corneal cell therapy moves closer
Corneal cells propagated in vitro can be injected into the cornea to restore vision to patients blinded by corneal endothelial disease, reported Aurion Biotech.
Staff reporters1 min read
Bionic eye looks to human trials
Researchers at the University of Sydney said their Phoenix99 bionic eye implant is ready for human trials, having demonstrated its safety in a three-month sheep model. Biomedical engineers Professor
Staff reporters1 min read
DR drops begin trial
OcuTerra Therapeutics has commenced phase 1b clinical trials of its OTT166 eye drops for patients with diabetic retinopathy (DR) and wet AMD, having demonstrated their safety, tolerability and clinical evidence of biological activity.
Staff reporters1 min read
App to diagnose concussion?
A smartphone video app can be used to evaluate concussion patients for recovery and measure compounding injuries, a new study found. The app, Reflex, identifies biomarkers that might be used in
Staff reporters2 min read
Smartphone braille keyboard ‘game changer’
Dutch start-up Hable has released a braille keyboard, Hable One, that fits in the palm of your hand. “Our vision is to make smartphones completely accessible for people who are blind,”
Staff reporters1 min read
A quest for accessible, accurate autorefraction
PlenOptika's QuickSee, a handheld autorefractor designed to reduce global uncorrected refractive error, can dramatically increase access to eyeglasses, according to researchers. The paper, published
Staff reporters2 min read
Carbon monoxide to combat DR?
More often associated with poisoning and death in poorly ventilated homes with old gas ranges, a new study suggests that carbon monoxide (CO) in very small doses may protect against diabetic retinopathy (DR).
Staff reporters2 min read
CL-disease monitoring a step closer
New contact lens (CL) technology designed to help diagnose and monitor medical conditions may soon be ready for clinical trials, revealed Purdue University researchers.
Staff reporters1 min read
Alcon’s US$475m Ivantis buy-out
American-Swiss surgical product company Alcon announced it will acquire Ivantis, makers of the minimally invasive glaucoma surgery (MIGS) device the Hydrus Microstent, for an initial US$475m.
Staff reporters1 min read
Eyestil Synfo drops for DED hit NZ
Medix 21 Surgical has introduced SIFI’s Eyestil Synfo moisturising eye drops for dry eye disease (DED) in New Zealand.
Staff reporters1 min read